Correlation Between ZyVersa Therapeutics and Abcellera Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Abcellera Biologics, you can compare the effects of market volatilities on ZyVersa Therapeutics and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Abcellera Biologics.

Diversification Opportunities for ZyVersa Therapeutics and Abcellera Biologics

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between ZyVersa and Abcellera is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Abcellera Biologics go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Abcellera Biologics

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Abcellera Biologics. In addition to that, ZyVersa Therapeutics is 2.66 times more volatile than Abcellera Biologics. It trades about -0.16 of its total potential returns per unit of risk. Abcellera Biologics is currently generating about 0.04 per unit of volatility. If you would invest  289.00  in Abcellera Biologics on August 28, 2024 and sell it today you would earn a total of  6.00  from holding Abcellera Biologics or generate 2.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ZyVersa Therapeutics  vs.  Abcellera Biologics

 Performance 
       Timeline  
ZyVersa Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Abcellera Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.

ZyVersa Therapeutics and Abcellera Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ZyVersa Therapeutics and Abcellera Biologics

The main advantage of trading using opposite ZyVersa Therapeutics and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.
The idea behind ZyVersa Therapeutics and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm